6 products found
Zetagen Therapeutics Inc. Products
-
Oncology
Zetagen is committed to the treatment of metastatic cancer lesions. Bone metastases are common among cancer patients and occur when cells from the primary cancerous tumor relocate to the bone. When these cancers relocate, they can cause changes to the bone, damaging it in a process called osteolysis. Osteolysis can cause small holes within the bone, weakening it and increasing the risk of breakage. These holes are called “lytic lesions.” Among cancers which metastasize to bone, Breast and Prostate are most prevalent, amounting to approximately 70-percent of cases.
-
ZetaMet - Synthetic Small-Molecule
ZetaMet is a synthetic, small-molecule, inductive biologic technology being developed to target and resolve metastatic bone lesions while inhibiting future tumor growth and regenerating bone. The small molecule has been approved by the U.S. Food and Drug Administration (FDA) since 1971. Zetagen scientists have discovered an entirely new pathway for this established molecule which, if proven successful in human clinical trials, could create a new ...
-
ZetaMet Settable - Vertebroplasty Procedure
ZetaMet Settable is being designed for the treatment of patients with metastatic lesions that have or will result in a Skeletal-Related Event, (SRE) including fractures and spinal cord ...
-
Musculoskeletal
Through Zetagen’s novel discovery, ancillary specialties will benefit from this discovery, such as Musculoskeletal fusion procedures.
-
ZetaFuse - Synthetic Small-Molecule
ZetaFuse is the first synthetic, small molecule, osteo-inductive biologic, to safely aid bone healing of spinal fusions. The U.S. Food and Drug Administration (FDA) has awarded ZetaFuse Breakthrough Device Designation[1] for the complete spinal column. ZetaFuse is driven by the activation of a novel molecular pathway, by leveraging this patented mechanism, to directly turn stem cells into osteoblasts (osteoinductive) and prevents bone resorption ...
-
ZetaSet - Synthetic Osteo
ZetaSet is the first synthetic, osteo-inductive, biologic designed specifically for the treatment of osteoporotic fractures, high energy injuries with bone defects, and for patients with fractures of the tibial plateau (knee) and plafond ...
-
ZetaBase - Osteo-Conductive and Osteo-Promotive Therapy
ZetaBase is an osteo-conductive and osteo-promotive therapy and is intended for the use as a bone void filler for bony voids or gaps that are not intrinsic to the stability of the bony structure. ZetaBase Bone Graft can be used as a bone graft ...
-
Craniomaxillofacial
Zetagen is committed to the treatment of craniomaxillofacial bone cancers through our breakthrough technologies. These discoveries, like ZetaDent™, have ancillary benefits to other oral procedures such as the 500,000 dental implants procedures completed annually.
-
ZetaDent - Osteo-Inductive Biologic System
ZetaDent is an osteo-inductive biologic intended to promote bone formation as a part of localized ridge augmentation procedures prior to dental implant placement, alveolar ridge reconstruction procedures for prosthetic treatment, and for filling of bone defects in the oral ...